Feb 10 (Reuters) - Shanghai Henlius Biotech Inc 2696.HK:
CO'S NEW DRUG APPLICATION OF INNOVATIVE SMALL MOLECULAR HLX99 ("HLX99") WAS APPROVED BY U.S. FDA
Further company coverage: 2696.HK
((Reuters.Briefs@thomsonreuters.com))
Feb 10 (Reuters) - Shanghai Henlius Biotech Inc 2696.HK:
CO'S NEW DRUG APPLICATION OF INNOVATIVE SMALL MOLECULAR HLX99 ("HLX99") WAS APPROVED BY U.S. FDA
Further company coverage: 2696.HK
((Reuters.Briefs@thomsonreuters.com))
Comments